Three novel sequence variations in the 5′ upstream region of the cystic fibrosis transmembrane conductance regulator (CFTR) gene: two polymorphisms and one putative molecular defect

More than 400 sequence alterations have been identified in the whole coding sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene corresponding to the 27 exons and their exon-intron boundaries. However, in some CF chromosomes, no mutation has yet been detected. In such cases, we have explored the promoter and the sequence up to position-1000 from the cap site, by using denaturing gradient gel electrophoresis. This study concerning 35 CF chromosomes has allowed us to identify three novel sequence variations located in the 5′ upstream region of the gene. The T to G substitution located at position -895 from the cap site could be considered as a polymorphic variation. The second substitution (C to T at position -816) has been detected on only one CF chromosome, but does not concern a regulatory DNA element previously described. Conversely, the third substitution (a T to G substitution at position -741 from the cap site) is located at a potential AP-1 binding site. We have investigated, by electrophoretic mobility shift assay, the ability of this region to bind nuclear factors. We have found that the normal sequence between -740/-745 does not bind either the AP-1 transcription factor or AP-1 related proteins, and that the T to G -741 mutated sequence exhibits an abnormal binding pattern suggesting the possible deleterious effect of still unknown negative trans-acting factors.

[1]  F. Collins,et al.  Characterization of the cystic fibrosis transmembrane conductance regulator promoter region. Chromatin context and tissue-specificity. , 1993, The Journal of biological chemistry.

[2]  M. Yaniv,et al.  Several distinct "CCAAT" box binding proteins coexist in eukaryotic cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Kaplan,et al.  Fernandez, E. et al. Use of chemical clamps in denaturing gradient gel electrophoresis: application in the detection of the most frequent Mediterranean -thalassemic mutations. PCR Methods Appl. 3, 122-124 , 1993 .

[4]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[5]  C. Chu,et al.  Down-regulation of cystic fibrosis gene mRNA transcript levels and induction of the cystic fibrosis chloride secretory phenotype in epithelial cells by phorbol ester. , 1991, The Journal of biological chemistry.

[6]  吉村 邦彦.  The cystic fibrosis gene has a "housekeeping"-type promoter and is expressed at low levels in cells of epithelial origin , 1992 .

[7]  J. Kaplan,et al.  Use of chemical clamps in denaturing gradient gel electrophoresis: application in the detection of the most frequent Mediterranean beta-thalassemic mutations. , 1993, PCR methods and applications.

[8]  E. Girodon,et al.  Psoralen-modified oligonucleotide primers improve detection of mutations by denaturing gradient gel electrophoresis and provide an alternative to GC-clamping. , 1993, Human molecular genetics.

[9]  M. Jeanpierre.  A rapid method for the purification of DNA from blood. , 1987, Nucleic acids research.

[10]  J. Riordan,et al.  Induction of expression of the cystic fibrosis transmembrane conductance regulator. , 1992, The Journal of biological chemistry.

[11]  L. Tsui,et al.  The spectrum of cystic fibrosis mutations. , 1992, Trends in genetics : TIG.

[12]  L. Tsui,et al.  Characterization of the promoter region of the cystic fibrosis transmembrane conductance regulator gene. , 1991, The Journal of biological chemistry.

[13]  U. Schibler,et al.  Tissue-specific in vitro transcription from the mouse albumin promoter , 1986, Cell.

[14]  Silke Meyer,et al.  Compilation of vertebrate-encoded transcription factors , 1992, Nucleic Acids Res..

[15]  C. Kedinger,et al.  Jun and Fos heterodimerize with ATFa, a member of the ATF/CREB family and modulate its transcriptional activity. , 1994, Oncogene.